REPORT ID 4136

United States Expressed Competent Cells Market Report 2017

Publish Date
15-Dec-17
Pages
109
Format
Electronic (PDF)

In this report, the United States Expressed Competent Cells market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:
    The West
    Southwest
    The Middle Atlantic
    New England
    The South
    The Midwest
with sales (volume), revenue (value), market share and growth rate of Expressed Competent Cells in these regions, from 2012 to 2022 (forecast).

United States Expressed Competent Cells market competition by top manufacturers/players, with Expressed Competent Cells sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
    Merck KGaA
    Thermo Fisher Scientific
    Agilent Technologies
    Takara Bio
    Promega Corporation
    Beijing TransGen Biotech
    GeneScript Corporation
    Yeastern Biotech
    New England Biolabs
    QIAGEN N.V.
    OriGene Technologies
    Lucigen
    Zymo Research
    Bio-Rad Laboratories
    Bioline
    Delphi Genetics
    IBA GmBH
    Cell Applications
    BioDynamics Laboratory
    Scarab Genomics

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    Chemically Competent Cells
    Electrocompetent Cells
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
    Protein Expression
    Other

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

United States Expressed Competent Cells Market Report 2017
1 Expressed Competent Cells Overview
    1.1 Product Overview and Scope of Expressed Competent Cells
    1.2 Classification of Expressed Competent Cells by Product Category
        1.2.1 United States Expressed Competent Cells Market Size (Sales Volume) Comparison by Type (2012-2022)
        1.2.2 United States Expressed Competent Cells Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
        1.2.3 Chemically Competent Cells
        1.2.4 Electrocompetent Cells
    1.3 United States Expressed Competent Cells Market by Application/End Users
        1.3.1 United States Expressed Competent Cells Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
        1.3.2 Protein Expression
        1.3.3 Other
    1.4 United States Expressed Competent Cells Market by Region
        1.4.1 United States Expressed Competent Cells Market Size (Value) Comparison by Region (2012-2022)
        1.4.2 The West Expressed Competent Cells Status and Prospect (2012-2022)
        1.4.3 Southwest Expressed Competent Cells Status and Prospect (2012-2022)
        1.4.4 The Middle Atlantic Expressed Competent Cells Status and Prospect (2012-2022)
        1.4.5 New England Expressed Competent Cells Status and Prospect (2012-2022)
        1.4.6 The South Expressed Competent Cells Status and Prospect (2012-2022)
        1.4.7 The Midwest Expressed Competent Cells Status and Prospect (2012-2022)
    1.5 United States Market Size (Value and Volume) of Expressed Competent Cells (2012-2022)
        1.5.1 United States Expressed Competent Cells Sales and Growth Rate (2012-2022)
        1.5.2 United States Expressed Competent Cells Revenue and Growth Rate (2012-2022)

2 United States Expressed Competent Cells Market Competition by Players/Suppliers
    2.1 United States Expressed Competent Cells Sales and Market Share of Key Players/Suppliers (2012-2017)
    2.2 United States Expressed Competent Cells Revenue and Share by Players/Suppliers (2012-2017)
    2.3 United States Expressed Competent Cells Average Price by Players/Suppliers (2012-2017)
    2.4 United States Expressed Competent Cells Market Competitive Situation and Trends
        2.4.1 United States Expressed Competent Cells Market Concentration Rate
        2.4.2 United States Expressed Competent Cells Market Share of Top 3 and Top 5 Players/Suppliers
        2.4.3 Mergers & Acquisitions, Expansion in United States Market
    2.5 United States Players/Suppliers Expressed Competent Cells Manufacturing Base Distribution, Sales Area, Product Type

3 United States Expressed Competent Cells Sales (Volume) and Revenue (Value) by Region (2012-2017)
    3.1 United States Expressed Competent Cells Sales and Market Share by Region (2012-2017)
    3.2 United States Expressed Competent Cells Revenue and Market Share by Region (2012-2017)
    3.3 United States Expressed Competent Cells Price by Region (2012-2017)

4 United States Expressed Competent Cells Sales (Volume) and Revenue (Value) by Type (Product Category) (2012-2017)
    4.1 United States Expressed Competent Cells Sales and Market Share by Type (Product Category) (2012-2017)
    4.2 United States Expressed Competent Cells Revenue and Market Share by Type (2012-2017)
    4.3 United States Expressed Competent Cells Price by Type (2012-2017)
    4.4 United States Expressed Competent Cells Sales Growth Rate by Type (2012-2017)

5 United States Expressed Competent Cells Sales (Volume) by Application (2012-2017)
    5.1 United States Expressed Competent Cells Sales and Market Share by Application (2012-2017)
    5.2 United States Expressed Competent Cells Sales Growth Rate by Application (2012-2017)
    5.3 Market Drivers and Opportunities

6  United States Expressed Competent Cells Players/Suppliers Profiles and Sales Data
    6.1 Merck KGaA
        6.1.1 Company Basic Information, Manufacturing Base and Competitors
        6.1.2 Expressed Competent Cells Product Category, Application and Specification
            6.1.2.1 Product A
            6.1.2.2 Product B
        6.1.3 Merck KGaA Expressed Competent Cells Sales, Revenue, Price and Gross Margin (2012-2017)
        6.1.4 Main Business/Business Overview
    6.2 Thermo Fisher Scientific
        6.2.2 Expressed Competent Cells Product Category, Application and Specification
            6.2.2.1 Product A
            6.2.2.2 Product B
        6.2.3 Thermo Fisher Scientific Expressed Competent Cells Sales, Revenue, Price and Gross Margin (2012-2017)
        6.2.4 Main Business/Business Overview
    6.3 Agilent Technologies
        6.3.2 Expressed Competent Cells Product Category, Application and Specification
            6.3.2.1 Product A
            6.3.2.2 Product B
        6.3.3 Agilent Technologies Expressed Competent Cells Sales, Revenue, Price and Gross Margin (2012-2017)
        6.3.4 Main Business/Business Overview
    6.4 Takara Bio
        6.4.2 Expressed Competent Cells Product Category, Application and Specification
            6.4.2.1 Product A
            6.4.2.2 Product B
        6.4.3 Takara Bio Expressed Competent Cells Sales, Revenue, Price and Gross Margin (2012-2017)
        6.4.4 Main Business/Business Overview
    6.5 Promega Corporation
        6.5.2 Expressed Competent Cells Product Category, Application and Specification
            6.5.2.1 Product A
            6.5.2.2 Product B
        6.5.3 Promega Corporation Expressed Competent Cells Sales, Revenue, Price and Gross Margin (2012-2017)
        6.5.4 Main Business/Business Overview
    6.6 Beijing TransGen Biotech
        6.6.2 Expressed Competent Cells Product Category, Application and Specification
            6.6.2.1 Product A
            6.6.2.2 Product B
        6.6.3 Beijing TransGen Biotech Expressed Competent Cells Sales, Revenue, Price and Gross Margin (2012-2017)
        6.6.4 Main Business/Business Overview
    6.7 GeneScript Corporation
        6.7.2 Expressed Competent Cells Product Category, Application and Specification
            6.7.2.1 Product A
            6.7.2.2 Product B
        6.7.3 GeneScript Corporation Expressed Competent Cells Sales, Revenue, Price and Gross Margin (2012-2017)
        6.7.4 Main Business/Business Overview
    6.8 Yeastern Biotech
        6.8.2 Expressed Competent Cells Product Category, Application and Specification
            6.8.2.1 Product A
            6.8.2.2 Product B
        6.8.3 Yeastern Biotech Expressed Competent Cells Sales, Revenue, Price and Gross Margin (2012-2017)
        6.8.4 Main Business/Business Overview
    6.9 New England Biolabs
        6.9.2 Expressed Competent Cells Product Category, Application and Specification
            6.9.2.1 Product A
            6.9.2.2 Product B
        6.9.3 New England Biolabs Expressed Competent Cells Sales, Revenue, Price and Gross Margin (2012-2017)
        6.9.4 Main Business/Business Overview
    6.10 QIAGEN N.V.
        6.10.2 Expressed Competent Cells Product Category, Application and Specification
            6.10.2.1 Product A
            6.10.2.2 Product B
        6.10.3 QIAGEN N.V. Expressed Competent Cells Sales, Revenue, Price and Gross Margin (2012-2017)
        6.10.4 Main Business/Business Overview
    6.11 OriGene Technologies
    6.12 Lucigen
    6.13 Zymo Research
    6.14 Bio-Rad Laboratories
    6.15 Bioline
    6.16 Delphi Genetics
    6.17 IBA GmBH
    6.18 Cell Applications
    6.19 BioDynamics Laboratory
    6.20 Scarab Genomics

7 Expressed Competent Cells Manufacturing Cost Analysis
    7.1 Expressed Competent Cells Key Raw Materials Analysis
        7.1.1 Key Raw Materials
        7.1.2 Price Trend of Key Raw Materials
        7.1.3 Key Suppliers of Raw Materials
        7.1.4 Market Concentration Rate of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
        7.2.1 Raw Materials
        7.2.2 Labor Cost
        7.2.3 Manufacturing Expenses
    7.3 Manufacturing Process Analysis of Expressed Competent Cells

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
    8.1 Expressed Competent Cells Industrial Chain Analysis
    8.2 Upstream Raw Materials Sourcing
    8.3 Raw Materials Sources of Expressed Competent Cells Major Manufacturers in 2016
    8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
    9.1 Marketing Channel
        9.1.1 Direct Marketing
        9.1.2 Indirect Marketing
        9.1.3 Marketing Channel Development Trend
    9.2 Market Positioning
        9.2.1 Pricing Strategy
        9.2.2 Brand Strategy
        9.2.3 Target Client
    9.3 Distributors/Traders List

10 Market Effect Factors Analysis
    10.1 Technology Progress/Risk
        10.1.1 Substitutes Threat
        10.1.2 Technology Progress in Related Industry
    10.2 Consumer Needs/Customer Preference Change
    10.3 Economic/Political Environmental Change

11 United States Expressed Competent Cells Market Size (Value and Volume) Forecast (2017-2022)
    11.1 United States Expressed Competent Cells Sales Volume, Revenue Forecast (2017-2022)
    11.2 United States Expressed Competent Cells Sales Volume Forecast by Type (2017-2022)
    11.3 United States Expressed Competent Cells Sales Volume Forecast by Application (2017-2022)
    11.4 United States Expressed Competent Cells Sales Volume Forecast by Region (2017-2022)

12 Research Findings and Conclusion

13 Appendix
    13.1 Methodology/Research Approach
        13.1.1 Research Programs/Design
        13.1.2 Market Size Estimation
        13.1.3 Market Breakdown and Data Triangulation
    13.2 Data Source
        13.2.1 Secondary Sources
        13.2.2 Primary Sources
    13.3 Disclaimer